Related Experiment Video
Updated: Jan 12, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Antiatherogenic and Cardioprotective Effects of a Xanthine Derivative KMUP-1 in ApoE Knockout Mice
Erna Sulistyowati1, Shang-En Huang2, Chih-Chieh Hsu2
1Department of Medicine, Faculty of Medicine, Universitas Islam Malang, Malang, East Java, Indonesia.
Abstract:
It is essential to manage cardiovascular disease related to atherosclerosis through understanding its disease progression mechanism. The effects of the xanthine derivative KMUP-1 on alleviating atherosclerosis and cardiac remodeling, as well as its underlying mechanisms, were examined. In this study, atherosclerosis and cardiac damage were induced in ApoE knockout (KO) mice by feeding them a high-fat diet (HFD) for 12 weeks. The co- and posttreatment of KMUP-1 was evaluated. Our results showed that KMUP-1 treatment significantly reduced body weight gain in HFD-induced mice. The Oil Red O and hematoxylin-eosin staining showed that KMUP-1 reduced the aortic plaque area, intima-media thickness, and intima-lumen thickness. KMUP-1 reduced inflammatory cytokines IL-1β, TNF-α, IL-6, and MCP-1 in the serum of mice through an ELISA assay. Moreover, echocardiography evaluation indicated that KMUP-1 attenuated left ventricular cardiac hypertrophy and restored cardiac function. Further, KMUP-1 treatment suppressed proapoptotic protein Bax and reversed Bcl-2 level by promoting autophagy-related Gene 7 and autophagosome marker LC3-II activation in the vascular through immunofluorescence and western blotting assay. KMUP-1 improved the serum lipidomic profile. Both co- and posttreatment of KMUP-1 stimulated autophagy and reduced inflammation and apoptosis, against atherosclerosis and cardiac remodeling in an ApoE-KO mouse model. It suggests its potential as a therapeutic agent for cardiovascular diseases.
Insights
The xanthine derivative KMUP-1 effectively combats atherosclerosis and cardiac remodeling in ApoE knockout mice by reducing inflammation and promoting autophagy, suggesting its therapeutic potential for cardiovascular diseases.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Molecular Biology
Background:
- Atherosclerosis and cardiac remodeling are key drivers of cardiovascular disease.
- Understanding disease progression mechanisms is crucial for effective management.
- Xanthine derivatives are being explored for therapeutic potential.
Purpose of the Study:
- To investigate the effects of KMUP-1 on atherosclerosis and cardiac remodeling.
- To elucidate the underlying mechanisms of KMUP-1's action.
- To evaluate KMUP-1 as a potential therapeutic agent for cardiovascular diseases.
Main Methods:
- Atherosclerosis and cardiac damage induced in ApoE knockout mice using a high-fat diet.
- Co- and posttreatment with KMUP-1 evaluated.
- Biochemical assays (ELISA), histological staining (Oil Red O, H&E), echocardiography, immunofluorescence, and Western blotting used.
Main Results:
- KMUP-1 significantly reduced body weight gain, aortic plaque area, and vascular thickness.
- Reduced serum levels of inflammatory cytokines (IL-1β, TNF-α, IL-6, MCP-1).
- Attenuated cardiac hypertrophy, restored cardiac function, improved lipid profiles, and modulated apoptosis/autophagy markers (Bax, Bcl-2, ATG7, LC3-II).
Conclusions:
- KMUP-1 treatment, both concurrently and subsequently, mitigates atherosclerosis and cardiac remodeling in a mouse model.
- KMUP-1 stimulates autophagy while reducing inflammation and apoptosis.
- KMUP-1 demonstrates significant potential as a therapeutic agent for cardiovascular diseases.

